Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity

被引:117
作者
Sleeman, J
Rudy, W
Hofmann, M
Moll, J
Herrlich, P
Ponta, H
机构
[1] Forschungszentrum Karlsruhe, Institute of Genetics
[2] Forschungszentrum Karlsruhe, Institute of Genetics, D-76021 Karlsruhe
关键词
D O I
10.1083/jcb.135.4.1139
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell contact with the extracellular matrix component hyaluronic acid (HA) plays an important role in many developmental, physiological, and pathological processes, although the regulation of this contact is poorly understood. CD44 proteins carry an amino acid motif that mediates affinity to HA. Artificial clustering of the smallest 85-kD isoform of CD44 (CD44s) has previously been shown to promote binding of the protein to soluble HA (Lesley, J., R. Hyman, and P.W. Kincade. 1993. Adv. Immunol. 54:271-335; Persche, A., J. Lesley, N. English, I. Trowbridge, and R. Hyman. 1995. Eur. J. Immunol. 25:495-501). Here we show that in rat pancreatic carcinoma cells, splice variants of CD44 (CD44v), but not CD44s, form molecular aggregates in the plasma membrane. We demonstrate that reduction-sensitive dimerization of CD44v occurs, and also that larger aggregations of the protein can be stabilized by chemical cross-linking. Different CD44v proteins present on the same cell exclusively form homoaggregates. Molecular clustering does not require an intact cytoplasmic domain of the protein. The ability of cells to bind to soluble HA is upregulated more than one magnitude by the ectopic expression of CD44v4-v7, but only when the CD44v4-v7 protein forms intermolecular aggregates. Tunicamycin treatment inhibits HA binding by CD44v and at the same time destroys oligomerization. We propose that the regulation of clustering of CD44, mediated by factors including the presence of variant exons and glycosylation, allows cells in turn to regulate their HA binding properties.
引用
收藏
页码:1139 / 1150
页数:12
相关论文
共 41 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[3]   Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan [J].
Bartolazzi, A ;
Nocks, A ;
Aruffo, A ;
Spring, F ;
Stamenkovic, I .
JOURNAL OF CELL BIOLOGY, 1996, 132 (06) :1199-1208
[4]   REGULATION OF CD44 BINDING TO HYALURONAN BY GLYCOSYLATION OF VARIABLY SPLICED EXONS [J].
BENNETT, KL ;
MODRELL, B ;
GREENFIELD, B ;
BARTOLAZZI, A ;
STAMENKOVIC, I ;
PEACH, R ;
JACKSON, DG ;
SPRING, F ;
ARUFFO, A .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1623-1633
[5]   A SUBPOPULATION OF MAC-1 (CD11B/CD18) MOLECULES MEDIATES NEUTROPHIL ADHESION TO ICAM-1 AND FIBRINOGEN [J].
DIAMOND, MS ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1993, 120 (02) :545-556
[6]  
DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074
[7]   CORRELATION OF CD2 BINDING AND FUNCTIONAL-PROPERTIES OF MULTIMERIC AND MONOMERIC LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3 [J].
DUSTIN, ML ;
OLIVE, D ;
SPRINGER, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (02) :503-517
[8]   A HUMAN-LYMPHOCYTE HOMING RECEPTOR, THE HERMES ANTIGEN, IS RELATED TO CARTILAGE PROTEOGLYCAN CORE AND LINK PROTEINS [J].
GOLDSTEIN, LA ;
ZHOU, DFH ;
PICKER, LJ ;
MINTY, CN ;
BARGATZE, RF ;
DING, JF ;
BUTCHER, EC .
CELL, 1989, 56 (06) :1063-1072
[9]  
GORMAN CM, 1985, DNA CLONING PRACTICA, P143
[10]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24